Novartis CEO Vas Narasimhan says cannabis is not a priority for the Swiss drugmaker despite its partnership with Canadian marijuana giant Tilray. Novartis NOVN-CH CEO Vas Narasimhan said Tuesday that cannabis is not a priority for the Swiss drugmaker despite its partnership with Canadian marijuana giant Tilray TLRY .